Oturum Aç

The Michaelis–Menten equation is a fundamental model for describing capacity-limited kinetics in drug metabolism. It offers insights into the rate of decline of plasma drug concentration Cp over time, with Vmax and KM as pivotal parameters.

Vmax represents the maximum achievable process rate, while KM, known as the Michaelis constant, signifies the drug concentration at which the process rate reaches half its maximum. This relationship between Vmax, KM, and Cp gives rise to three distinct scenarios that shed light on the dynamics of drug metabolism.

First, when KM = Cp, the process rate operates at half its maximum capacity. Conversely, if KM > Cp, the process rate mirrors first-order elimination, a pattern typically observed in most drugs at therapeutic levels. On the other hand, when KM < Cp, the process maintains a constant rate akin to zero-order elimination. Certain drugs, such as salicylates and phenytoin, follow first-order kinetics at lower therapeutic doses. In this state, the rate of drug elimination is proportional to the drug concentration. However, when these drugs are administered at elevated therapeutic doses, their metabolism saturates the hepatic mixed-function oxidases. This saturation shifts the kinetics to a zero-order pattern, where the elimination rate becomes constant and independent of drug concentration. The graphical representation of the Michaelis–Menten equation, known as the Michaelis–Menten plot, illustrates an initial linear rate increase with concentration, transitioning to mixed-order kinetics at higher concentrations and ultimately culminating in a plateau at Vmax.

In summary, the Michaelis–Menten equation serves as a foundational tool for understanding the intricacies of capacity-limited drug metabolism. It delineates the interplay between Vmax, KM, and Cp in shaping the rate of drug elimination within the body.

Bölümden 8:

article

Now Playing

8.3 : Nonlinear Pharmacokinetics: Michaelis-Menten Equation

Nonlinear Pharmacokinetics

108 Görüntüleme Sayısı

article

8.1 : Nonlinear Pharmacokinetics: Overview

Nonlinear Pharmacokinetics

165 Görüntüleme Sayısı

article

8.2 : Nonlinear Pharmacokinetics: Causes of Nonlinearity

Nonlinear Pharmacokinetics

55 Görüntüleme Sayısı

article

8.4 : Determination of Michaelis Constant and Maximum Elimination Rate

Nonlinear Pharmacokinetics

38 Görüntüleme Sayısı

article

8.5 : Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection

Nonlinear Pharmacokinetics

19 Görüntüleme Sayısı

article

8.6 : Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview

Nonlinear Pharmacokinetics

19 Görüntüleme Sayısı

article

8.7 : Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model

Nonlinear Pharmacokinetics

20 Görüntüleme Sayısı

article

8.8 : Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

Nonlinear Pharmacokinetics

30 Görüntüleme Sayısı

article

8.9 : Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Nonlinear Pharmacokinetics

29 Görüntüleme Sayısı

article

8.10 : Chronopharmacokinetics: Time-Dependent Pharmacokinetics

Nonlinear Pharmacokinetics

51 Görüntüleme Sayısı

article

8.11 : Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding

Nonlinear Pharmacokinetics

63 Görüntüleme Sayısı

article

8.12 : Nonlinear Pharmacokinetics: Role of Transporters

Nonlinear Pharmacokinetics

16 Görüntüleme Sayısı

JoVE Logo

Gizlilik

Kullanım Şartları

İlkeler

Araştırma

Eğitim

JoVE Hakkında

Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır